627MO POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic non–small cell lung cancer (mNSCLC)
作者
Shiyuan Lu,О. І. Vynnychenko,Yaroslav Kulyaba,Vladimer Kuchava,A. Ibrahim,Fedor Vladimirovich Moiseenko,C. Arslan,D.T. Nguyen,M. Zhang,M.D. Petrovic,I. Cicin,K. Bibichadze,Timuçin Çil,Mark J. Cornfeld,Chuan Tian,M. Munteanu,Cláudia Vaz de Melo Sette,Igor Bondarenko
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2024-12-01卷期号:35: S1633-S1634被引量:1